HELIO

Heliospectra

Market Cap 278.8M

Heliospectra specializes in intelligent lighting systems for plant research, greenhouse cultivation and controlled environment agriculture. The company is a global leader in LED grow lights for advanced research applications and has patented technology.

+ more

Redeye Research

Reports

Notes

Today
Day High
8.10
8
Day Low
7.96
Day Open
7.96
Prev Close
7.94
VWAP
8.0
Volume
71K
Turnover
0.572M
Top Broker
AVA
VWAP
8.3
Avg Volume
158K
Avg Turnover
1.304M
Top Brokers
AVA/SWB
VWAP
8.1
Avg Volume
162K
Avg Turnover
1.309M
Top Brokers
AVA/NON
VWAP
7.9
Avg Volume
115K
Avg Turnover
0.916M
Top Brokers
AVA/NON
52 week summary
Price Range
3.5
Last
11.2
Beta
N/A
Market Cap
278.8M
Total Return
98.0%
Trailing P/E
-9.4
Div Yield
0.0%
Shares Outstanding
35.1M
Next Earnings Date
24 Aug
Stock Exchange
First North Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Change 3 Months 10.1%
Change 12 Months 110.6%
Volume Trend
Average Volume 10 vs 60 Days 21.6%
Price VS
52 Week High -28.3%
50 Day Moving Average 4.8%
200 Day moving Average 17.0%

Add article markers

Compare Heliospectra to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Ali Ahmadian, CEO
  • Magnus Svensson, CFO
  • Executive board
  • Andreas Gunnarsson, Chairman of the board
  • Anders Ludvigsson
  • Martin Skoglund
  • Göran Larsson
Last updated: 2018-04-27 Source: Redeye
Major Owners Equity Votes
Gösta Welandson med bolag 34.4%
34.4%
Mohammed Al Amoudi 10.1%
10.1%
Avanza Pension 5.9%
5.9%
Piba AB 1.1%
1.1%
Magowny Invest AB 1.0%
1.0%
Nordnet Pensionsförsäkring 0.9%
0.9%
Andreas Arnewid 0.8%
0.8%
Kent Gustafson 0.7%
0.7%
Rolf Johansson 0.7%
0.7%
Chrilotte AB 0.7%
0.7%
Last updated: 2018-04-27 Source: Redeye/Holdings
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2015
  •  
  • -153.5%
  • -85.4%
  • -164.5%
  • -208.1%
  • -236.5%
  • -248.1%
  •  
  • -1.82
  • -1.82
  • 0.00
  •  
  • 18.6
  •  
  • 205.9
  • -6.0
  • -6.0
  • 14.8
  • 15.0
  • -7.2
  • -6.4
  • 7.2
  •  
  • 56.4%
  • 9.7%
  • 3
  • 31
  • 0.3
  • 2015
  •  
  •  
  • 19
  • 7
  • 7
  • 0
  • 33
  •  
  • 1
  • 0
  • 0
  • 0
  • 0
  • 16
  • 0
  • 17
  • 0
  • 50
  •  
  •  
  • 9
  • 0
  • 0
  • 9
  • 13
  • 0
  • 0
  • 22
  • 0
  • 0
  • 28
  • 0
  • 28
  • 50
  • 2015
  • 14
  • -42
  • -4
  • -32
  • 0
  • -32
  • 4
  • -28
  • -11
  • -4
  • -44
  • 2015 Q2
  • 2
  • -9
  • -7
  • -1
  • 0
  • 0
  • -8
  • 0
  • 0
  • 0
  • -8
  • 0
  • -8
  • 2015 Q3
  • 2
  • -9
  • -7
  • -1
  • 0
  • 0
  • -8
  • 0
  • 0
  • 0
  • -8
  • 0
  • -8
  • 2015 Q4
  • 8
  • -17
  • -9
  • -1
  • 0
  • 0
  • -10
  • 0
  • -1
  • 0
  • -11
  • 0
  • -11
  • 2016
  •  
  • -83.5%
  • -60.1%
  • -137.5%
  • -166.7%
  • -185.5%
  • -198.5%
  •  
  • -1.30
  • -1.30
  • 0.00
  •  
  • 35.1
  •  
  • 208.3
  • -5.9
  • -5.9
  • 11.7
  • 9.0
  • -5.4
  • -4.9
  • 3.3
  •  
  • 77.4%
  • 3.9%
  • -62
  • 19
  • 0.2
  • 2016
  •  
  •  
  • 73
  • 6
  • 8
  • 0
  • 87
  •  
  • 2
  • 0
  • 0
  • 0
  • 0
  • 17
  • 0
  • 18
  • 0
  • 105
  •  
  •  
  • 0
  • 13
  • 0
  • 13
  • 11
  • 0
  • 0
  • 24
  • 0
  • 0
  • 81
  • 0
  • 81
  • 105
  • 2016
  • 23
  • -61
  • -4
  • -43
  • 0
  • -43
  • 4
  • -38
  • 12
  • -5
  • -31
  • 2016 Q1
  • 5
  • -13
  • -8
  • -1
  • 0
  • 0
  • -9
  • 0
  • 0
  • 0
  • -9
  • 0
  • -9
  • 2016 Q2
  • 5
  • -15
  • -10
  • -1
  • 0
  • 0
  • -11
  • 0
  • 0
  • 0
  • -11
  • 0
  • -11
  • 2016 Q3
  • 6
  • -15
  • -9
  • -1
  • 0
  • 0
  • -10
  • 0
  • 0
  • 0
  • -10
  • 0
  • -10
  • 2016 Q4
  • 7
  • -18
  • -11
  • -1
  • 0
  • 0
  • -12
  • 0
  • -3
  • 0
  • -15
  • 0
  • -15
  • 2017
  •  
  • -51.1%
  • -46.3%
  • -170.1%
  • -79.8%
  • -91.8%
  • -92.0%
  •  
  • -0.94
  • -0.94
  • 0.00
  •  
  • 35.1
  •  
  • 109.0
  • -4.4
  • -4.4
  • 4.1
  • 3.0
  • -3.8
  • -3.3
  • 3.1
  •  
  • 65.0%
  • 1.5%
  • -38
  • 10
  • 0.5
  • 2017
  •  
  •  
  • 41
  • 10
  • 8
  • 0
  • 58
  •  
  • 1
  • 0
  • 0
  • 0
  • 0
  • 15
  • 0
  • 16
  • 0
  • 74
  •  
  •  
  • 0
  • 15
  • 0
  • 16
  • 2
  • 9
  • 0
  • 26
  • 0
  • 0
  • 48
  • 0
  • 48
  • 74
  • 2017
  • 36
  • -65
  • -4
  • -33
  • 0
  • -33
  • 4
  • -29
  • -1
  • -2
  • -24
  • 2017 Q1
  • 4
  • -13
  • -9
  • -1
  • 0
  • 0
  • -10
  • 0
  • 0
  • 0
  • -10
  • 0
  • -10
  • 2017 Q2
  • 8
  • -15
  • -7
  • -1
  • 0
  • 0
  • -8
  • 0
  • 0
  • 0
  • -8
  • 0
  • -8
  • 2017 Q3
  • 8
  • -14
  • -6
  • -1
  • 0
  • 0
  • -7
  • 0
  • 0
  • 0
  • -7
  • 0
  • -7
  • 2017 Q4
  • 16
  • -23
  • -6
  • -1
  • 0
  • 0
  • -7
  • 0
  • 0
  • 0
  • -7
  • 0
  • -7
  • 2018 E
  • 2018 E
  • 2018 E
  • 2018 Q1
  • 9
  • -16
  • -6
  • -1
  • 0
  • 0
  • -7
  • 0
  • 0
  • 0
  • -7
  • 0
  • -7
  • 2018 Q2 E
  • 2018 Q3 E
  • 2018 Q4 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2019 Q1 E
  • 2019 Q2 E
  • 2019 Q3 E
  • 2019 Q4 E
  • 2020 E
  • 2020 E
  • 2020 E
  • 2020 Q1 E
  • 2020 Q2 E

Estimated Values are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2018-04-28 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.

Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.